Instructions for the Patient
Women of childbearing age should be advised of the consequences of second- and third-trimester fetal exposure to AT-II-receptor antagonists and should be instructed to report their pregnancy to their physician as soon as possible. Patients taking losartan should be advised not to use potassium supplements or salt substitutes containing potassium because of the potential for increased serum potassium levels.
Am J Health Syst Pharm. 2000;57(13) © 2000 American Society of Health-System Pharmacists
Cite this: Angiotensin II-Receptor Antagonists: An Overview - Medscape - Jul 01, 2000.
Comments